Unless it carried a HUGE premium. As undervalued as this stock is, I'd be very concerned about a hostile takeover. That alone should give management some incentive to do something to promote the stock.
There has been much said about the company not issuing sufficient press releases. In 1998 Atrix issued 18 press releases, twice as many as Alkermes. That is also more than Colagenex and KeraVison issued, two companies that have been mentioned on this board as doing a good job with PR. I suppose next we'll here the argument that Atrix's press releases are ineffective. I also suppose I'll be attacked again for mentioning these facts.
I've never mentioned Colagenex or Keravision. How long did you have to search to find 2 companies with fewer press releases than Atrix? I wish I had the statiscal average for NASDAQ company press releases over 1998.
The facts you've ignored are:
Atrix is already operating with a profit, and is expected to continue to do so for the coming 2 fiscal years.
Alerkermes already had established solid relationship with Wall Street. That's why they have 9 analysts covering it to ATRX's 2. Since a low in Oct. 98, Alkermes has tripled from it's low around 10/share to just above 31/share. Alkermes is also not expected to make a profit for several more years. Current Estimates are: Current (1999) $-1.08 Next (2000) $-0.94
While KeraVision only has 2 analysts, it has also tripled from the Oct. 98 low around 4/share to around 12/share. Kera is also not expected to make a profit for several more years. Current Estimates are: Current (1998) $-2.12
Next (1999) $-1.74
Collagenex has traded similarly to ATRX w/ 98 low around 6/share. Even though it too has only 2 analysts providing coverage, it is now around 12 (Doubled from low). Collagenex is also not expected to make a profit for several more years. Current Estimates are: CGPI Current (1998) $-1.42 Next (1999) $-1.40
Worst case, Atrix could have at least doubled to 15 (2 x low of 7.625) given the above, but they just don't manage their relationship with the street very well and the stock price reflects this.
You don't seem to understand the key factors that drive valuation. I poliltely encourge you to do your homework more thoroughly before you post to help with credibility.
Collagenex, at their company web site http://www.collagenex.com has 16 press releases and if you count the SEC required filings like you did for ATRIX, you get 21 (4 quarters plus annual =5). Once again, more than ATRIX.
Finally ATRX had an extraordinary item, Virotex acquisition, where there were 3 press releases. Also, you counted the Warburg Dillon downgrade of ATRIX - NEAT, but you can count it. You even counted Southard�s retirement, that�s ok too!
I didn't even waste more time to check out Keravision given the fact you're already quite imcompetent.
These facts render your comment useless. Now I why other posters have referred to you as tetrazero!!